Monsanto’s venture arm leads $24m Series C
The firm co-led the round in biologicals start-up NewLeaf Symbiotics alongside Otter Capital, bringing capital raised by the company to nearly $50m.
The firm co-led the round in biologicals start-up NewLeaf Symbiotics alongside Otter Capital, bringing capital raised by the company to nearly $50m.
Copyright PEI Media
Not for publication, email or dissemination